7z57 - Revision history

OCA at 13:29, 1 February 2024

OCA — Thu, 01 Feb 2024 13:29:03 GMT

←Older revision		Revision as of 13:29, 1 February 2024
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[7z57]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7Z57 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7Z57 FirstGlance]. <br>		<table><tr><td colspan='2'>[[7z57]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7Z57 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7Z57 FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BR:BROMIDE+ION'>BR</scene>, <scene name='pdbligand=IGB:(2R)-2,3,3,3-tetrakis(fluoranyl)-2-[1,1,2,2,3,3,3-heptakis(fluoranyl)propoxy]propanoic+acid'>IGB</scene>, <scene name='pdbligand=MPD:(4S)-2-METHYL-2,4-PENTANEDIOL'>MPD</scene>, <scene name='pdbligand=MYR:MYRISTIC+ACID'>MYR</scene></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.2Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BR:BROMIDE+ION'>BR</scene>, <scene name='pdbligand=IGB:(2R)-2,3,3,3-tetrakis(fluoranyl)-2-[1,1,2,2,3,3,3-heptakis(fluoranyl)propoxy]propanoic+acid'>IGB</scene>, <scene name='pdbligand=MPD:(4S)-2-METHYL-2,4-PENTANEDIOL'>MPD</scene>, <scene name='pdbligand=MYR:MYRISTIC+ACID'>MYR</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7z57 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7z57 OCA], [https://pdbe.org/7z57 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7z57 RCSB], [https://www.ebi.ac.uk/pdbsum/7z57 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7z57 ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7z57 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7z57 OCA], [https://pdbe.org/7z57 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7z57 RCSB], [https://www.ebi.ac.uk/pdbsum/7z57 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7z57 ProSAT]</span></td></tr>
	</table>		</table>

OCA at 11:04, 30 November 2022

OCA — Wed, 30 Nov 2022 11:04:49 GMT

←Older revision		Revision as of 11:04, 30 November 2022
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 7z57 is ~~ON HOLD until Paper~~ Publication	+	==Crystal structure of Human Serum Albumin in complex with surfactant GenX (2,3,3,3-tetrafluoro-2-(heptafluoropropoxy) propanoate)==
		+	<StructureSection load='7z57' size='340' side='right'caption='[[7z57]], [[Resolution\|resolution]] 2.20Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[7z57]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7Z57 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7Z57 FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BR:BROMIDE+ION'>BR</scene>, <scene name='pdbligand=IGB:(2R)-2,3,3,3-tetrakis(fluoranyl)-2-[1,1,2,2,3,3,3-heptakis(fluoranyl)propoxy]propanoic+acid'>IGB</scene>, <scene name='pdbligand=MPD:(4S)-2-METHYL-2,4-PENTANEDIOL'>MPD</scene>, <scene name='pdbligand=MYR:MYRISTIC+ACID'>MYR</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7z57 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7z57 OCA], [https://pdbe.org/7z57 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7z57 RCSB], [https://www.ebi.ac.uk/pdbsum/7z57 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7z57 ProSAT]</span></td></tr>
		+	</table>
		+	== Disease ==
		+	[https://www.uniprot.org/uniprot/ALBU_HUMAN ALBU_HUMAN] Defects in ALB are a cause of familial dysalbuminemic hyperthyroxinemia (FDH) [MIM:[https://omim.org/entry/103600 103600]. FDH is a form of euthyroid hyperthyroxinemia that is due to increased affinity of ALB for T(4). It is the most common cause of inherited euthyroid hyperthyroxinemia in Caucasian population.<ref>PMID:8048949</ref> <ref>PMID:7852505</ref> <ref>PMID:9329347</ref> <ref>PMID:9589637</ref>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/ALBU_HUMAN ALBU_HUMAN] Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc.<ref>PMID:19021548</ref>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	The current trend dealing with the production of per- and polyfluoroalkyl substances (PFASs) involves the shifting toward branched short-chain fluorinated compounds known as new-generation PFASs. A key aspect to be clarified, to address the adverse health effects associated with the exposure to PFASs, is their binding mode to human serum albumin (hSA), the most abundant protein in plasma. In this study, we investigated the interaction between hSA and two representative branched short-chain PFASs, namely, HPFO-DA and C6O4. In-solution studies revealed that both compounds bind hSA with affinities and stoichiometries lower than that of the legacy long-chain perfluoroalkyl compound PFOA. Competition experiments using hSA-binding drugs with known site-selectivity revealed that both HPFO-DA and C6O4 bound to pockets located in subdomain IIIA. The crystal structure of hSA in complex with HPFO-DA unveiled the presence of two binding sites. The characterization and direct comparison of hSA interactions with new-generation PFASs may be key elements for the understanding of the toxicological impact of these compounds.

-	~~Authors: Liberi, S~~., Moro, G., ~~Vascon~~, F., Linciano, S., De Toni, L~~., Angelin~~, A., Cendron, L.	+	Investigation of the Interaction between Human Serum Albumin and Branched Short-Chain Perfluoroalkyl Compounds.,Moro G, Liberi S, Vascon F, Linciano S, De Felice S, Fasolato S, Foresta C, De Toni L, Di Nisio A, Cendron L, Angelini A Chem Res Toxicol. 2022 Nov 21;35(11):2049-2058. doi: , 10.1021/acs.chemrestox.2c00211. Epub 2022 Sep 23. PMID:36148994<ref>PMID:36148994</ref>

-	~~Description: Crystal structure of Human Serum Albumin in complex with surfactant GenX (2~~,~~3,3,3~~-~~tetrafluoro~~-~~2-(heptafluoropropoxy) propanoate)~~	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	[[Category: ~~Unreleased Structures~~]]	+	</div>
-	[[Category: ~~Angelin, A~~]]	+	<div class="pdbe-citations 7z57" style="background-color:#fffaf0;"></div>
-	[[Category: ~~Vascon, F~~]]	+	== References ==
-	[[Category: ~~Liberi, S~~]]	+	<references/>
-	[[Category: De Toni, L]]	+	__TOC__
-	[[Category: ~~Moro, G~~]]	+	</StructureSection>
-	[[Category: Linciano, S]]	+	[[Category: Homo sapiens]]
-	[[Category: ~~Cendron, L~~]]	+	[[Category: Large Structures]]
		+	[[Category: Angelin A]]
		+	[[Category: Cendron L]]
		+	[[Category: De Toni L]]
		+	[[Category: Liberi S]]
		+	[[Category: Linciano S]]
		+	[[Category: Moro G]]
		+	[[Category: Vascon F]]

OCA at 10:37, 27 April 2022

OCA — Wed, 27 Apr 2022 10:37:51 GMT

←Older revision		Revision as of 10:37, 27 April 2022
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 7z57 is ON HOLD	+	The entry 7z57 is ON HOLD until Paper Publication

	Authors: Liberi, S., Moro, G., Vascon, F., Linciano, S., De Toni, L., Angelin, A., Cendron, L.		Authors: Liberi, S., Moro, G., Vascon, F., Linciano, S., De Toni, L., Angelin, A., Cendron, L.

OCA: Protected "7z57" [edit=sysop:move=sysop]

OCA — Wed, 16 Mar 2022 05:18:08 GMT

Protected "7z57" [edit=sysop:move=sysop]

←Older revision

Revision as of 05:18, 16 March 2022

OCA: New page: '''Unreleased structure''' The entry 7z57 is ON HOLD Authors: Liberi, S., Moro, G., Vascon, F., Linciano, S., De Toni, L., Angelin, A., Cendron, L. Description: Crystal structure of Hu...

OCA — Wed, 16 Mar 2022 05:18:07 GMT

New page: '''Unreleased structure''' The entry 7z57 is ON HOLD Authors: Liberi, S., Moro, G., Vascon, F., Linciano, S., De Toni, L., Angelin, A., Cendron, L. Description: Crystal structure of Hu...

New page

'''Unreleased structure'''

The entry 7z57 is ON HOLD

Authors: Liberi, S., Moro, G., Vascon, F., Linciano, S., De Toni, L., Angelin, A., Cendron, L.

Description: Crystal structure of Human Serum Albumin in complex with surfactant GenX (2,3,3,3-tetrafluoro-2-(heptafluoropropoxy) propanoate)
[[Category: Unreleased Structures]]
[[Category: Angelin, A]]
[[Category: Vascon, F]]
[[Category: Liberi, S]]
[[Category: De Toni, L]]
[[Category: Moro, G]]
[[Category: Linciano, S]]
[[Category: Cendron, L]]